POINT Biopharma Global Inc
NASDAQ:PNT 4:00:00 PM EDT
| Market Cap (Intraday) | 694.03M |
| Current PE | 7.13 |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $7.00 |
| 50-Day MA | $8.05 |
| 200-Day MA | $8.09 |
POINT Biopharma Global Inc Stock, NASDAQ:PNT
4850 West 78th Street, 18th floor, Indianapolis, Indiana 46268
United States of America
Phone: +1.647.812.2417
Number of Employees: 129
Description
POINT Biopharma Global, Inc. is a radiopharmaceutical company. It engages in the business of building a platform for the clinical development and commercialization of radioligands that fight cancer. The company was founded by Joe McCann and Neil E. Fleshner on April 15, 2020 and is headquartered in Indianapolis, IN.